YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 17, 16:00
4601.65
-94.35 (-2.01%)
VOLUME 21,208
LIVE
NSE
Feb 17, 16:01
4600.55
-96.05 (-2.05%)
VOLUME 1,021,355
News on Dr Reddys Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Hold Dr Reddys Labs for long term: Mehta 

3.08 pm | 23 Dec 2010 |  Source: CNBC-TV18

Dr Reddys Labs is expected to grow at rate of around 26-27% in next 2-3 years. ROEs on capital employed would be around 22-23% and its fairly valued a...

Hold Dr Reddys Labs: Paul 

3.05 pm | 23 Dec 2010 |  Source: CNBC-TV18

As long as supports close to Rs 1575-1550 holds, Dr Reddys Labs is very likely to bounce back. Whether it takes out Rs 1800-1775 need to see. If one h...

Dr Reddy's Labs may come down: Gupta 

5.16 pm | 22 Dec 2010 |  Source: CNBC-TV18

Dr Reddy Labs certainly had a very tragic event. It should have a fairly significant downside impact on the stock, says Radhika Gupta of Forefront Cap...

Gas leak at Dr Reddy's plant in Andhra Pradesh kills two 

12.58 pm | 22 Dec 2010 |  Source: Reuters

Dr Reddy's Laboratories said on Wednesday authorities were investigating the deaths of an employee and a contractor working at its drug-making unit in...

Dr Reddy's in licensing deal with Russian firm

8.34 pm | 21 Dec 2010 |  Source: Reuters

Dr. Reddy's Laboratories said on Tuesday it has signed an agreement with Russia's R-Pharm for licensing, technology transfer, manufacturing and market...

Hold Dr Reddys Laboratories: Anu Jain 

10.05 am | 20 Dec 2010 |  Source: CNBC-TV18

Hold Dr Reddys Laboratories, says Anu Jain, Vice President, IIFL Private Wealth Management....

NPPA asks cos to pay Rs 2000cr for overpricing drugs

3.13 pm | 10 Dec 2010 |  Source: Moneycontrol.com

The National Pharmaceutical Pricing Authority (NPPA) has asked pharmaceutical companies to pay Rs 2,000 crore for overpricing drugs, reports CNBC-TV18...

Thacker bullish on IT, pharma sector 

5.51 pm | 03 Dec 2010 |  Source: CNBC-TV18

Mitesh Thacker, Technical Analyst, miteshthacker.com is bullish on IT, pharma sector....

Dr Reddy's buys Glaxo's US penicillin business

8.33 am | 24 Nov 2010 |  Source: Reuters

GlaxoSmithKline is getting out of the oral penicillin business in the United States, selling a factory and two key brands to India's Dr. Reddy's Labor...

Seth bullish on Dr Reddy and Sun Pharma 

7.00 pm | 18 Nov 2010 |  Source: CNBC-TV18

Prashastha Seth, Senior VP, IIFL Private Wealth is bullish on Dr Reddys Labs and Sun Pharma....

Ranbaxy may do well in medium-long term view: Mehta 

5.58 pm | 11 Nov 2010 |  Source: CNBC-TV18

Dr Reddys Labs may do well in medium to long term perspective, says Dipan Mehta, Member of BSE & NSE....

Sandeep Bhatia remains overweight on banks, auto 

1.00 pm | 11 Nov 2010 |  Source: CNBC-TV18

Sandeep Bhatia of Kotak Institutional Equities remains overweight on banking and auto stocks....

Accumulate Dr Reddys Labs: Emkay Global Financial Services

1.36 pm | 30 Oct 2010 |  Source: Moneycontrol.com

Emkay Global Financial Services is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 1763 in its Octobe...

Dr Reddys Labs a market performer: Karvy Stock Broking

1.24 pm | 30 Oct 2010 |  Source: Moneycontrol.com

Karvy Stock Broking has given a market performer rating on Dr Reddys Laboratories with a target of Rs 1702 in its October 25, 2010 research report....

Hold Dr Reddys Labs; target of Rs 1786: KRChoksey

7.24 pm | 29 Oct 2010 |  Source: Moneycontrol.com

KRChoksey has recommended hold rating on Dr Reddys Labs with a target of Rs 1786 in its October 26, 2010 research report....

Buy Dr Reddys Labs; target of Rs 1680: Motilal Oswal

6.38 pm | 29 Oct 2010 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1680 in its October 22, 2010 research repor...

Hold Dr Reddys Labs; target of Rs 1554: PINC Research

7.18 pm | 26 Oct 2010 |  Source: Moneycontrol.com

PINC Research has recommended hold rating on Dr Reddys Labs with a target of Rs 1554 in its October 25, 2010 research report....

Dr Reddys Laboratories reports Rs 1,296.88 crore turnover for quarter ended Sep 2010

7.13 pm | 26 Oct 2010 |  Source: Moneycontrol.com

Dr Reddys Laboratories has reported a sales turnover of Rs 1,296.88 crore and a net profit of Rs 220.20 crore for the quarter ended Sep 2010...

DRL sees Russia as growth driver, says US recovery slow 

11.40 am | 25 Oct 2010 |  Source: CNBC-TV18

Dr Reddy's Laboratories has reports a 11.68% growth in its net profit for the second quarter of fiscal year 2011. The growth in India has been better ...

Dr Reddy's Labs Q2 net profit up 11.68% at Rs 220 cr

1.32 pm | 23 Oct 2010 |  Source: Moneycontrol.com

Pharma major Dr Reddy's Laboratories has announced its second quarter results of FY11. It has reported net profit at Rs 220 crore as against Rs 197 cr...

1 2 3 4
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.